Christine Tunon de Lara
Overview
Explore the profile of Christine Tunon de Lara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
719
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Houvenaeghel G, de Nonneville A, Cohen M, Classe J, Reyal F, Mazouni C, et al.
Eur J Cancer
. 2022 Oct;
176:58-69.
PMID: 36194904
Introduction: Few data have been reported regarding endocrine therapy (ET) in patients with small pT1a-b ER-postive breast cancer (BC). Thus, we conducted a study to detect possible survival improvements due...
2.
Houvenaeghel G, de Nonneville A, Chopin N, Classe J, Mazouni C, Chauvet M, et al.
Cancer Med
. 2022 Sep;
12(4):4023-4032.
PMID: 36127853
Background: Results of IBCSG-23-01-trial which included breast cancer patients with involved sentinel nodes (SN) by isolated-tumor-cells or micro-metastases supported the non-inferiority of completion axillary-lymph-node-dissection (cALND) omission. However, current data are...
3.
Maire M, Debled M, Petit A, Fournier M, MacGrogan G, Quenel-Thueux N, et al.
Eur J Surg Oncol
. 2022 May;
48(8):1699-1705.
PMID: 35523623
Background: The reverse sequence of neoadjuvant chemotherapy, preoperative radiotherapy, mastectomy then immediate breast reconstruction is currently proposed for selected patients with locally advanced breast cancer. Few studies have compared it...
4.
Jones N, Gros A, Velasco V, Dapremont V, Brouste V, Gastaldello B, et al.
Cancer Genet
. 2022 Mar;
264-265:8-15.
PMID: 35263698
The similarities between sporadic basal-like breast cancer (BLBC) and BRCA1-mutated breast tumours raise the possibility that deregulation of the same pathway may underlie these tumour types. The aim of this...
5.
Houvenaeghel G, Cohen M, Raro P, De Troyer J, Gimbergues P, Tunon de Lara C, et al.
NPJ Breast Cancer
. 2021 Oct;
7(1):133.
PMID: 34625562
Based on results of clinical trials, completion ALND (cALND) is frequently not performed for patients with breast conservation therapy and one or two involved sentinel nodes (SN) by micro- or...
6.
Mangiardi-Veltin M, Chammings F, Jaffre A, Rousvoal A, Tunon de Lara C, Brouste V, et al.
Bull Cancer
. 2021 Sep;
108(11):999-1009.
PMID: 34556291
Introduction: Women identified as high-risk for breast cancer may choose between close follow-up and radical mastectomy. Prophylactic mastectomy, as any other surgery, is associated with benefits and harms. The aim...
7.
Houvenaeghel G, El Hajj H, Barrou J, Cohen M, Raro P, De Troyer J, et al.
Cancers (Basel)
. 2020 Oct;
12(10).
PMID: 33050650
Many trials confirmed the safety of omitting axillary dissection in the selected patients treated for early breast cancer. The external validity of these trials is questionable. Our study aimed to...
8.
Uzan C, Mazouni C, Rossoni C, De Korvin B, Tunon de Lara C, Cohen M, et al.
Ann Surg Oncol
. 2020 Sep;
28(4):2138-2145.
PMID: 32920723
Background: Diagnosis of atypical breast lesions (ABLs) leads to unnecessary surgery in 75-90% of women. We have previously developed a model including age, complete radiological target excision after biopsy, and...
9.
Payne A, Merrill R, Minalga E, Hadley J, Odeen H, Hofstetter L, et al.
IEEE Trans Biomed Eng
. 2020 Aug;
68(3):893-904.
PMID: 32784128
Objective: This paper presents and evaluates a breast-specific magnetic resonance guided focused ultrasound (MRgFUS) system. A first-in-human evaluation demonstrates the novel hardware, a sophisticated tumor targeting algorithm and a volumetric...
10.
Lerebours F, Pulido M, Fourme E, Debled M, Becette V, Bonnefoi H, et al.
Br J Cancer
. 2020 Feb;
122(6):759-765.
PMID: 32001832
Background: Few data are available on survival and predictive factors in early breast cancer (BC) patients treated with neoadjuvant endocrine therapy (NET). Methods: This is a pooled analysis of two...